申请人:AstraZeneca AB
公开号:US06465481B1
公开(公告)日:2002-10-15
There is provided compounds of formula I,
wherein R1, R2, R3, R4, R5a, R5b, R6, R9, X, A and B have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
提供了化合物I的公式,其中R1、R2、R3、R4、R5a、R5b、R6、R9、X、A和B的含义如描述中所述,这些化合物在预防和治疗心律失常方面特别是房性和室性心律失常中有用。